I Got Scammed... Not all peptide sources are safe

Peptide Testing Insights

Introduction to Peptide Discussion

• The video introduces a discussion on peptide information, focusing on behind-the-scenes insights that are often not shared publicly.

• Viewers are encouraged to subscribe and join the Discord community, which has nearly a thousand members discussing various topics including peptides, fitness, nutrition, and more.

Overview of Peptide Testing

• The speaker mentions conducting extensive testing on approximately 20 different peptides from their latest batch.

• Each batch of peptides is tested for quality assurance by sending samples to Freedom Diagnostics at a cost of about $350 per vial.

Results of Peptide Testing

• The first product discussed is a red-topped GLP3 radatride with a concentration of 10 mg; it contains 11.82 mg of GLP3 with a purity level of 97.86%.

• The speaker reassures viewers that while some excipients may be present in the vials affecting purity levels, they would still confidently inject the tested products.

Additional Product Findings

• Two yellow-topped GLP3 products were tested: one with 10.75 mg (purity 99.73%) and another with 11.31 mg (purity 99.92%).

• A green-topped GLP3 vial showed results of 11.67 mg and purity at 99.64%, indicating high-quality standards across multiple products.

Further Analysis on Purity Levels

• A separate analysis revealed that a GLP1 vial contained 10.53 mg with a purity level of 99.55%, while a GLP2 vial had slightly higher content at 11.55 mg and purity at 99.75%.

• The Glow product was noted for its popularity among researchers; it returned lower than expected net peptide content but maintained an effective purity level at 99.43%.

Understanding Acceptable Variations in Vial Content

• The speaker discusses acceptable variations in peptide content based on vial size; for example, minor discrepancies are tolerable within certain limits depending on the total milligram amount intended for each vial.

Product Testing and Quality Assurance in Peptides

Overview of Product Dosing Accuracy

• The product's dosing was confirmed to be accurate, with TB500 testing at 9.19 mg instead of the expected 10 mg, and BPC 157 at 9.99 mg.

• The speaker expresses satisfaction with the results, emphasizing that the products are solid and properly dosed.

Introduction of SLU PP332 Injectable Form

• A new injectable product, SLU PP332, is introduced; it has not been sold yet but is anticipated in the research space.

• The speaker purchased a limited number of vials for personal testing to evaluate its effectiveness compared to tablets.

Testing Results and Lab Relationships

• Initial test results showed unexpected purity levels (99% MSI), raising concerns about potential lab errors or mislabeling.

• The speaker discusses their trust in lab relationships, asserting that there’s no incentive for labs to scam customers.

Analysis of Potential Lab Errors

• A hypothetical scenario is presented where a lab could replace SLU with a cheaper alternative without detection by inexperienced users.

• The speaker believes that any discrepancies likely stem from human error rather than intentional deceit.

Response to Lab Issues and Future Steps

• After reporting the issue back to the lab, they expressed apologies and acknowledged a serious mistake may have occurred during packaging.

Understanding Mistakes in Business Operations

The Nature of Mistakes

• The speaker emphasizes that their error rate is very low, under 1%, with only one or two mistakes occurring each month. They express frustration over these errors but acknowledge that they are a part of the process.

• A specific mistake is described where a customer received mislabeled vials: one labeled correctly and another without a label. This incident highlights the importance of double-checking items before shipping.

• The speaker reflects on the silliness of the mistake, noting that it could have been avoided if proper checks were conducted. They stress the need for careful attention to detail in operations.

Learning from Errors

• The discussion continues about how rushing can lead to mistakes, suggesting that taking time to verify details can prevent errors from happening in the first place.

• The speaker identifies as a perfectionist, which complicates their ability to delegate tasks like packing and email responses. They recognize that not everyone will meet their standards, yet they must accept this reality.

Quality Control Measures

• It’s advised that customers should also test products themselves due to potential errors from suppliers. Trusting suppliers is important, but additional testing provides an extra layer of assurance.

• Recommendations are made for researchers to conduct their own tests when possible, especially if budget allows, ensuring confidence in product quality and accuracy.

Product Testing Results

• Updates on product testing reveal that SLU PP332's injectable version is currently on hold pending new batch testing.

• SS31 was tested at 10 mg and returned a purity level just below expectations at 99.85%. Despite being good quality, there’s disappointment regarding its performance compared to desired standards.

Additional Product Insights

• Other products such as Tessarellin and Ipamearellin show promising results with high purity levels (98%+), indicating reliable quality control measures are in place for most offerings.

• Challenges arise with tablet testing; while COAs confirm content identification (e.g., SLU PP332), purity cannot be guaranteed due to handling factors affecting tablets' integrity during production and distribution.

Understanding Customer Service in Business

Importance of Accountability in Customer Service

• A good company prioritizes customer satisfaction and accountability, ensuring they address issues without blaming the customer.

• The speaker emphasizes that companies should be quick to rectify mistakes, reflecting a commitment to service rather than frustration towards customers.

• Mistakes are acknowledged as part of business operations; however, companies must strive to minimize them for longevity and success.

Compliance and Industry Challenges

• Recent closures of labs raise concerns within the industry; the speaker hints at ongoing challenges but reassures listeners about their compliance efforts.